NrCAM in addiction vulnerability: Positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice

Neuropsychopharmacology

Volumn 31, Issue 3, 2006, Pages 572-584

  Ishiguro, Hiroki ^a   Liu, Qing Rong ^a   Gong, Jian Ping ^a   Hall, Frank Scott ^a   Ujike, Hiroshi ^b   Morales, Marisela ^a   Sakurai, Takeshi ^c   Grumet, Martin ^d   Uhl, George R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Addiction; Association; Gene regulation; Morphine; Neuronal adhesion

Indexed keywords

AMPHETAMINE; CELL ADHESION MOLECULE; COCAINE; COMPLEMENTARY DNA; MESSENGER RNA; MORPHINE;

ADULT; ALLELE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MALE; MEMORY; MOLECULAR CLONING; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACE PREFERENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; REWARD; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BLOTTING, NORTHERN; BRAIN CHEMISTRY; CELL ADHESION MOLECULES; CHROMOSOME MAPPING; CLONING, MOLECULAR; COCAINE; COCAINE-RELATED DISORDERS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENOME, HUMAN; GENOTYPE; HAPLOTYPES; HUMANS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MORPHINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; RNA, MESSENGER; SUBSTANCE-RELATED DISORDERS;

EID: 33244494176     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300855     Document Type: Article

References (49)

1. Bierut LJ, Rice JP, Goate A, Hinrichs AL, Saccone NL, Foroud T et al (2004). A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. Am J Med Genet A 124: 19-27.
2. Bonora E, Lamb JA, Barnby G, Sykes N, Moberly T, Beyer KS et al (2005). Mutation screening and association analysis of six candidate genes for autism on chromosome 7q. Eur J Hum Genet 13: 198-207.
3. Douglas J, McKinzie AA, Couceyro P (1995). PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15: 2471-2481.
4. Dunckley T, Lukas RJ (2003). Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J Biol Chem 278: 15633-15640.
5. Grigorenko E, Kittler J, Clayton C, Wallace D, Zhuang S, Bridges D et al (2002). Assessment of cannabinoid induced gene changes: tolerance and neuroprotection. Chem Phys Lipids 121: 257-266.
6. Grumet M (1997). Nr-CAM: a cell adhesion molecule with ligand and receptor functions. Cell Tissue Res 290: 423-428.
7. Gynther LM, Carey G, Gottesman II, Vogler GP (1995). A twin study of non-alcohol substance abuse. Psychiatry Res 56: 213-220.
8. Hall FS, Goeb M, Li XF, Sora I, Uhl GR (2004). μ-opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. Mol Brain Res 121: 123-130.
9. Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H et al (1998). Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 22: 845-848.
10. Karkowski LM, Prescott CA, Kendler KS, Neale MC (2000). Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. Am J Med Genet 96: 665-670.
11. Kendler KS, Karkowski LM, Neale MC, Prescott CA (2000). Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57: 261-269.
12. Kendler KS, Karkowski LM, Prescott CA (1999). The assessment of dependence in the study of stressful life events: validation using a twin design. Psychol Med 29: 1455-1460.
13. Kendler KS, Neale MC, Heath AC, Kessler RC, Eaves LJ, Goodwin DW (1994). A twin-family study of alcoholism in women Familial alcoholism: a separate entity? Am J Psychiatry 151: 707-715.
14. Kendler KS, Prescott CA (1998). Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 155: 1016-1022.
15. Kolkova K, Novitskaya V, Pedersen N, Berezin V, Bock E (2000). Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway. J Neurosci 20: 2238-2246.
16. Liu QR, Lopez-Corcuera B, Mandiyan S, Nelson H, Nelson N (1993). Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected]. J Biol Chem 268: 2106-2112.
17. Liu QR, Zhang PW, Zhen Q, Walther D, Wang XB, Uhl GR (2002). KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine. J Biol Chem 277: 13312-13320.
18. Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, Moore E et al (1998). Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 81: 216-221.
19. McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O (2002). Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci Lett 326: 155-158.
20. Merikangas KR, Swendsen JD, Preisig MA, Chazan RZ (1998). Psychopathology and temperament in parents and offspring: results of a family study. J Affect Disord 51: 63-74.
21. Miller MW, Luo J (2002). Effects of ethanol and transforming growth factor beta (TGF beta) on neuronal proliferation and nCAM expression. Alcohol Clin Exp Res 26: 1281-1285.
22. Morales M, Bloom FE (1997). The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci 17: 3157-3167.
23. Moriwaki A, Wang JB, Svingos A, van Bockstaele E, Cheng P, Pickel V et al (1996). mu Opiate receptor immunoreactivity in rat central nervous system. Neurochem Res 21: 1315-1331.
24. Niculescu III AB, Kelsoe JR (2001). Convergent functional genomics: application to bipolar disorder. Ann Med 33: 263-271.
25. Persico AM, Bird G, Gabbay FH, Uhl GR (1996). D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 40: 776-784.
26. Reich T (1996). A genomic survey of alcohol dependence and related phenotypes: results from the Collaborative Study on the Genetics of Alcoholism (COGA). Alcohol Clin Exp Res 20: 133A-137A.
27. Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P et al (1998). Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 81: 207-215.
28. Sakurai T, Lustig M, Nativ M, Hemperly JJ, Schlessinger J, Peles E et al (1997). Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. J Cell Biol 136: 907-918.
29. Savoie CJ, Aburatani S, Watanabe S, Eguchi Y, Muta S, Imoto S et al (2003). Use of gene networks from full genome microarray libraries to identify functionally relevant drug-affected genes and gene regulation cascades. DNA Res 10: 19-25.
30. Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G, Lemmon V (1999). Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem 274: 37965-37973.
31. Schafer GL, Crabbe JC, Wiren KM (2001). Ethanol-regulated gene expression of neuroendocrine specific protein in mice: brain region and genotype specificity. Brain Res 897: 139-149.
32. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al (1992). Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 49: 723-727.
33. Sokolov BP, Polesskaya OO, Uhl GR (2003). Mouse brain gene expression changes after acute and chronic amphetamine. J Neurochem 84: 244-252.
34. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB et al (2001). Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98: 5300-5305.
35. Stallings MC, Hewitt JK, Beresford T, Heath AC, Eaves LJ (1999). A twin study of drinking and smoking onset and latencies from first use to regular use. Behav Genet 29: 409-421.
36. Toyooka K, Usui M, Washiyama K, Kumanishi T, Takahashi Y (2002). Gene expression profiles in the brain from phencyclidine-treated mouse by using DNA microarray. Ann NY Acad Sci 965: 10-20.
37. True WR, Heath AC, Scherrer JF, Xian H, Lin N, Eisen SA et al (1999a). Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. Am J Med Genet 88: 391-397.
38. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC et al (1999b). Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56: 655-661.
39. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N et al (1996). Genetic influences on DSM-III-R drug abuse and dependence: a study of 3, 372 twin pairs. Am J Med Genet 67: 473-477.
40. Tsuang MT, Lyons MJ, Harley RM, Xian H, Eisen S, Goldberg J et al (1999). Genetic and environmental influences on transitions in drug use. Behav Genet 29: 473-479.
41. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J et al (1998). Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55: 967-972.
42. Uhl GR (1999). Molecular genetics of substance abuse vulnerability: a current approach. Neuropsychopharmacology 20: 3-9.
43. Uhl GR (2004). Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results. Ann NY Acad Sci 1025: 1-13.
44. Uhl GR, Gold LH, Risch N (1997). Genetic analyses of complex behavioral disorders. Proc Natl Acad Sci USA 94: 2785-2786.
45. Uhl GR, Kitayama S (1993). A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis. Adv Neurol 60: 321-324.
46. Uhl GR, Liu QR, Naiman D (2002). Substance abuse vulnerability loci: converging genome scanning data. Trends Genet 18: 420-425.
47. Uhl GR, Liu QR, Walther D, Hess J, Naiman D (2001). Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet 69: 1290-1300.
48. Wang B, Williams H, Du JS, Terrett J, Kenwrick S (1998). Alternative splicing of human NrCAM in neural and nonneural tissues. Mol Cell Neurosci 10: 287-295.
49. Wang XB, Funada M, Imai Y, Revay RS, Ujike H, Vandenbergh DJ et al (1997). rGbeta1: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J Neurosci 17: 5993-6000.